Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	myofibril	NRAP SYNE1 SPTAN1 OBSCN FHOD3 RYR2 KCNA5 RTL1 HRC NBR1 ALPG	3.51e-05	273	186	11	GO:0030016
GeneOntologyCellularComponent	contractile muscle fiber	NRAP SYNE1 SPTAN1 OBSCN FHOD3 RYR2 KCNA5 RTL1 HRC NBR1 ALPG	6.06e-05	290	186	11	GO:0043292
GeneOntologyCellularComponent	Z disc	NRAP SPTAN1 OBSCN FHOD3 RYR2 KCNA5 RTL1 HRC	6.35e-05	151	186	8	GO:0030018
GeneOntologyCellularComponent	sarcomere	NRAP SYNE1 SPTAN1 OBSCN FHOD3 RYR2 KCNA5 RTL1 HRC NBR1	8.21e-05	249	186	10	GO:0030017
GeneOntologyCellularComponent	I band	NRAP SPTAN1 OBSCN FHOD3 RYR2 KCNA5 RTL1 HRC	1.23e-04	166	186	8	GO:0031674
GeneOntologyCellularComponent	cell-cell junction	NRAP SPTAN1 ASH1L OBSCN DBN1 PCDH12 NPHP4 PTK7 CDH24 EFNA5 KCNA5 MLC1 TLN1 PARD3 PCDH9	2.74e-04	591	186	15	GO:0005911
GeneOntologyCellularComponent	sarcoplasmic reticulum membrane	JSRP1 RYR2 ITPR2 HRC	6.80e-04	45	186	4	GO:0033017
GeneOntologyCellularComponent	supramolecular fiber	NUSAP1 COL11A2 NRAP MAP1A MAPT SYNE1 SPTAN1 OBSCN FHOD3 DBN1 MAP3K1 RYR2 GRIP1 HOOK3 KCNA5 RTL1 MICAL2 NAV3 HRC MACF1 NBR1 ALPG	8.25e-04	1179	186	22	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	NUSAP1 COL11A2 NRAP MAP1A MAPT SYNE1 SPTAN1 OBSCN FHOD3 DBN1 MAP3K1 RYR2 GRIP1 HOOK3 KCNA5 RTL1 MICAL2 NAV3 HRC MACF1 NBR1 ALPG	9.01e-04	1187	186	22	GO:0099081
GeneOntologyCellularComponent	axon	CAD COMT MAP1A MAPT SPTAN1 CRTAC1 DBN1 CBL MADD OPRK1 PTK7 ITPR2 GRIP1 PTPRZ1 MAST1 PARD3 MGARP PCDH9	1.04e-03	891	186	18	GO:0030424
GeneOntologyCellularComponent	sarcoplasmic reticulum	JSRP1 RYR2 OPRK1 ITPR2 HRC	1.14e-03	88	186	5	GO:0016529
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	3.92e-06	4	187	3	IPR029423
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	3.92e-06	4	187	3	PF14914
Domain	LRRC37_N	LRRC37A3 LRRC37A2 LRRC37A	3.92e-06	4	187	3	IPR032754
Domain	LRRC37	LRRC37A3 LRRC37A2 LRRC37A	3.92e-06	4	187	3	PF15779
Domain	LRRC37A/B-like	LRRC37A3 LRRC37A2 LRRC37A	3.92e-06	4	187	3	IPR015753
Domain	CH	SYNE1 LRCH1 MICAL2 LRCH4 NAV3 MACF1	4.70e-05	65	187	6	SM00033
Domain	CH	SYNE1 LRCH1 MICAL2 LRCH4 NAV3 MACF1	7.16e-05	70	187	6	PF00307
Domain	Spectrin	DRP2 SYNE1 SPTAN1 MACF1	7.42e-05	23	187	4	PF00435
Domain	-	SYNE1 LRCH1 MICAL2 LRCH4 NAV3 MACF1	7.76e-05	71	187	6	1.10.418.10
Domain	CH	SYNE1 LRCH1 MICAL2 LRCH4 NAV3 MACF1	9.07e-05	73	187	6	PS50021
Domain	CH-domain	SYNE1 LRCH1 MICAL2 LRCH4 NAV3 MACF1	1.06e-04	75	187	6	IPR001715
Domain	Cadherin_CS	FAT4 PCDHGA5 PCDH12 PCDH17 CDH24 DCHS1 PCDH9	1.14e-04	109	187	7	IPR020894
Domain	CADHERIN_1	FAT4 PCDHGA5 PCDH12 PCDH17 CDH24 DCHS1 PCDH9	1.42e-04	113	187	7	PS00232
Domain	Cadherin	FAT4 PCDHGA5 PCDH12 PCDH17 CDH24 DCHS1 PCDH9	1.42e-04	113	187	7	PF00028
Domain	CADHERIN_2	FAT4 PCDHGA5 PCDH12 PCDH17 CDH24 DCHS1 PCDH9	1.51e-04	114	187	7	PS50268
Domain	-	FAT4 PCDHGA5 PCDH12 PCDH17 CDH24 DCHS1 PCDH9	1.51e-04	114	187	7	2.60.40.60
Domain	CA	FAT4 PCDHGA5 PCDH12 PCDH17 CDH24 DCHS1 PCDH9	1.59e-04	115	187	7	SM00112
Domain	Cadherin-like	FAT4 PCDHGA5 PCDH12 PCDH17 CDH24 DCHS1 PCDH9	1.68e-04	116	187	7	IPR015919
Domain	Cadherin	FAT4 PCDHGA5 PCDH12 PCDH17 CDH24 DCHS1 PCDH9	1.86e-04	118	187	7	IPR002126
Domain	Spectrin_repeat	DRP2 SYNE1 SPTAN1 MACF1	1.90e-04	29	187	4	IPR002017
Domain	SPEC	DRP2 SYNE1 SPTAN1 MACF1	2.81e-04	32	187	4	SM00150
Domain	Spectrin/alpha-actinin	DRP2 SYNE1 SPTAN1 MACF1	2.81e-04	32	187	4	IPR018159
Domain	Laminin_G	HSPG2 FAT4 COL11A2 COL20A1 NRXN2	2.84e-04	58	187	5	IPR001791
Domain	PTCB-BRCT	MCPH1 PAXIP1	5.90e-04	4	187	2	PF12738
Domain	-	NID2 IGFBP1 IGFBP2	6.06e-04	17	187	3	4.10.800.10
Domain	Thyroglobulin_1	NID2 IGFBP1 IGFBP2	6.06e-04	17	187	3	IPR000716
Domain	THYROGLOBULIN_1_1	NID2 IGFBP1 IGFBP2	6.06e-04	17	187	3	PS00484
Domain	TY	NID2 IGFBP1 IGFBP2	6.06e-04	17	187	3	SM00211
Domain	THYROGLOBULIN_1_2	NID2 IGFBP1 IGFBP2	6.06e-04	17	187	3	PS51162
Domain	Thyroglobulin_1	NID2 IGFBP1 IGFBP2	6.06e-04	17	187	3	PF00086
Domain	Laminin_G_2	HSPG2 FAT4 COL11A2 NRXN2	6.71e-04	40	187	4	PF02210
Domain	ZF_ZZ_2	DRP2 HERC2 NBR1	7.21e-04	18	187	3	PS50135
Domain	ZF_ZZ_1	DRP2 HERC2 NBR1	7.21e-04	18	187	3	PS01357
Domain	ZZ	DRP2 HERC2 NBR1	7.21e-04	18	187	3	PF00569
Domain	Znf_ZZ	DRP2 HERC2 NBR1	8.50e-04	19	187	3	IPR000433
Domain	BRCT	MCPH1 PAXIP1 TP53BP1	8.50e-04	19	187	3	PF00533
Domain	ZnF_ZZ	DRP2 HERC2 NBR1	8.50e-04	19	187	3	SM00291
Domain	LamG	HSPG2 FAT4 COL11A2 NRXN2	9.66e-04	44	187	4	SM00282
Domain	BRCT	MCPH1 PAXIP1 TP53BP1	1.32e-03	22	187	3	SM00292
Domain	IGFBP1-6	IGFBP1 IGFBP2	1.46e-03	6	187	2	IPR009168
Domain	RIH_assoc-dom	RYR2 ITPR2	1.46e-03	6	187	2	IPR013662
Domain	IGFBP_1-6_chordata	IGFBP1 IGFBP2	1.46e-03	6	187	2	IPR022321
Domain	Ins145_P3_rec	RYR2 ITPR2	1.46e-03	6	187	2	PF08709
Domain	RIH_assoc	RYR2 ITPR2	1.46e-03	6	187	2	PF08454
Domain	RIH_dom	RYR2 ITPR2	1.46e-03	6	187	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 ITPR2	1.46e-03	6	187	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 ITPR2	1.46e-03	6	187	2	IPR015925
Domain	-	RYR2 ITPR2	1.46e-03	6	187	2	1.25.10.30
Domain	RYDR_ITPR	RYR2 ITPR2	1.46e-03	6	187	2	PF01365
Domain	-	MCPH1 PAXIP1 TP53BP1	1.51e-03	23	187	3	3.40.50.10190
Domain	SANT	DMTF1 BDP1 CHD6 CRAMP1	1.56e-03	50	187	4	SM00717
Domain	SANT/Myb	DMTF1 BDP1 CHD6 CRAMP1	1.81e-03	52	187	4	IPR001005
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	WDR7 IFT172 SYNE1 ARHGEF12 GRB10 MADD NEDD4 KANSL1 MEGF9 BAZ2A MLC1 TLN1 RRP12 NAV3 MAST1 MACF1 CHD6 SPEN	1.44e-11	407	191	18	12693553
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GPI IL12RB1 STRN3 CAD WARS1 MAP1A WDR7 MAPT SYNE1 SPTAN1 ARHGEF12 NBEA DBN1 SUCLA2 MADD ITPR2 EEF2 FAU ATP6V1H SAFB NRXN2 FGD4 FAM120C PTPRZ1 MICAL2 CRACDL TLN1 MAST1 MACF1	1.36e-09	1431	191	29	37142655
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 ANKS6 RASA3 PIEZO1 OBSCN GRB10 TBC1D25 RNF40 ANKLE1 NPHP4 MADD ITPR2 NOD2 KANSL1 TLN1 RRP12 BANP PAXIP1 HERC2 ZNF839 SPEN DHX34 CRAMP1 WDR24	1.11e-08	1105	191	24	35748872
Pubmed	Functional proteomics mapping of a human signaling pathway.	DMTF1 NID2 HSPG2 FLT4 ASH1L ETS2 RYR2 NEDD4 ZNF512B GRIP1 TOX4 KANSL1 PAXIP1 MACF1 RNF216 CHD6 HERC2	3.45e-08	591	191	17	15231748
Pubmed	Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins.	RASA3 COL20A1 LENG1 ZBTB8B NBEA ANKLE1 MAP3K6 ZNF512B ZNF668 SAFB MEGF9 MLC1 FAM120C PIGX PARD3 USPL1 DHX34 DKKL1 BICC1 WDR24	3.97e-08	832	191	20	36724073
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	BDP1 ABAT MIA3 MCPH1 RASA3 MAPT ASH1L OBSCN GRB10 SUCLA2 INKA2 PTK7 EFNA5 NACC2 FAM120C MICAL2 BANP MAST1 MACF1 FOXP1 CHD6 DHRSX PARD3 ZNF839 ARHGEF26 NBR1 CRAMP1	5.33e-08	1489	191	27	28611215
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	IFT172 SPTAN1 ARHGEF12 RNF40 MADD RPS6KC1 EEF2 SAFB KANSL1 FAM120C NAV3 CHD6 HERC2 PARD3 TP53BP1	6.87e-08	475	191	15	31040226
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	STRN3 MIA3 CAD WDR7 SYNE1 SPTAN1 ARHGEF12 NBEA JAKMIP3 DBN1 NEDD4 EEF2 HOOK3 FAM120C DCHS1 MACF1 HERC2 PARD3 ARHGEF26 TP53BP1	4.10e-07	963	191	20	28671696
Pubmed	A human MAP kinase interactome.	CASP8AP2 MAP1A SYNE1 SPTAN1 CBL MADD TOX4 KANSL1 NAV3 MACF1 CHD6 HERC2 USF2 ZNF839	5.73e-07	486	191	14	20936779
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A3 LRRC37A2 LRRC37A	6.50e-07	4	191	3	22419166
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	WARS1 IFT172 SYNE1 SPTAN1 ASH1L ETS2 CRTAC1 NBEA RNF40 JAKMIP3 MADD ZNF512B EEF2 MEGF9 MICAL2 NAV3 PKNOX1 MAST1 MACF1 RNF216 CHD6 HERC2 USPL1	7.08e-07	1285	191	23	35914814
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	STRN3 ABAT MIA3 CAD WARS1 MAP1A MAPT SPTAN1 NBEA DBN1 SUCLA2 RYR2 MADD PTK7 RPS6KC1 FAU SAFB FAM120C NAV3 MACF1 TP53BP1	1.40e-06	1139	191	21	36417873
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	GARIN5B IL12RB1 RAB11B STRN3 COL20A1 PCDHGA5 SYNE1 SPTAN1 ASH1L ZBTB41 DBN1 JSRP1 RYR2 PTK7 RPS6KC1 EEF2 SAFB ACSM3 TCHHL1 MACF1 CHD6 USPL1 SPEN TASOR	1.43e-06	1442	191	24	35575683
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	POLD1 NEXMIF SYNE1 SPTAN1 RNF40 RYR2 TOX4 TLN1 MACF1	1.58e-06	197	191	9	20811636
Pubmed	Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalization.	GRB10 CBL NEDD4	1.62e-06	5	191	3	28794017
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	NUSAP1 CASP8AP2 PHF20 MCPH1 RNF40 RREB1 ZNF512B ZNF668 FAU TOX4 SAFB KANSL1 TBRG1 USP42 BAZ2A RRP12 BANP PAXIP1 CHD6 USF2 SPEN TASOR	2.89e-06	1294	191	22	30804502
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	FAT4 MCPH1 NEXMIF OBSCN NBEA ZBTB41 AMER3 BCL3 PCDH17 ITPR2 RPS6KC1 R3HCC1L TM2D2 FAM120C TLN1 CHD6	3.51e-06	736	191	16	29676528
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CASP8AP2 SYNE1 LRCH1 SALL2 NRXN2 MLC1 TLN1 MACF1 CHD6	4.70e-06	225	191	9	12168954
Pubmed	Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations.	GPI CAD SPTAN1 DBN1 SUCLA2 AHSA1 ATP6V1H TLN1 MACF1	6.69e-06	235	191	9	28378594
Pubmed	Loss of connectin novex-3 leads to heart dysfunction associated with impaired cardiomyocyte proliferation and abnormal nuclear mechanics.	NUSAP1 SYNE1 OBSCN RYR2	1.02e-05	25	191	4	38877142
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	DMTF1 MYF5 NRAP PHF20 ASH1L ZBTB8B ETS2 ZBTB41 BCL3 IKZF5 ZNF668 TOX4 BAZ2A PKNOX1 FOXP1 USF2	1.12e-05	808	191	16	20412781
Pubmed	A census of human transcription factors: function, expression and evolution.	DMTF1 MYF5 PHF20 NRL ASH1L ETS2 NR4A3 RREB1 NKX2-8 TOX4 SALL2 DMRT2 ZFHX4 PKNOX1 FOXP1 USF2 CRAMP1	1.22e-05	908	191	17	19274049
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	NID2 STRN3 ANKS6 CAD MAP1A SPTAN1 OBSCN GRB10 DBN1 NPHP4 SLC5A3 EEF2 NAV3	1.61e-05	564	191	13	21565611
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GPI STRN3 WARS1 MAP1A CDKN2AIP DBN1 AHSA1 ZNF512B TOX4 SAFB R3HCC1L BAZ2A TLN1 RRP12 MACF1 TASOR TP53BP1	1.75e-05	934	191	17	33916271
Pubmed	Evolutionary dynamism of the primate LRRC37 gene family.	LRRC37A3 LRRC37A2 LRRC37A	1.90e-05	10	191	3	23064749
Pubmed	A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.	SLC29A3 NRAP FAM13C UNC5B CRTAC1 JAKMIP3 R3HCC1L RRP12 PARD3 VWA2 BICC1	2.07e-05	415	191	11	16385451
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	CASP8AP2 RNF40 RREB1 TOX4 SALL2 ZFHX4 KIAA1958 FOXP1 CHD6 TASOR S100PBP	2.21e-05	418	191	11	34709266
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	MAP1A WDR7 MAPT SPTAN1 NBEA DBN1 SUCLA2 MADD PRRT3 MACF1	2.44e-05	347	191	10	17114649
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CASP8AP2 MIA3 CAD POLD1 UNC5B SYNE1 PIEZO1 SPTAN1 SUCLA2 PTK7 ITPR2 SLC5A3 ZNF512B R3HCC1L BAZ2A TLN1 RRP12 MACF1 HERC2 PARD3 NBR1 TP53BP1	2.52e-05	1487	191	22	33957083
Pubmed	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	DMTF1 FAT4 SYNE1	2.60e-05	11	191	3	20351715
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	STRN3 MAPT SPTAN1 DBN1 RREB1 EEF2 SAFB KANSL1 USP42 BAZ2A RRP12 KIAA1958 PARD3 SPEN TP53BP1	2.73e-05	774	191	15	15302935
Pubmed	The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.	COMT MAPT	3.00e-05	2	191	2	19812213
Pubmed	Complexes between insulin-like growth factor binding proteins and alpha-2-macroglobulin in patients with tumor.	IGFBP1 IGFBP2	3.00e-05	2	191	2	25746666
Pubmed	Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse.	MAPT KANSL1	3.00e-05	2	191	2	21492964
Pubmed	Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation.	FLT4 VEGFD	3.00e-05	2	191	2	16624815
Pubmed	IGFBP-1 and IGFBP-2 are associated with a decreased pulse-wave velocity in young, healthy adults.	IGFBP1 IGFBP2	3.00e-05	2	191	2	33706704
Pubmed	Mitochondrial calcium overload is a key determinant in heart failure.	RYR2 ITPR2	3.00e-05	2	191	2	26217001
Pubmed	Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons.	MAPT KANSL1	3.00e-05	2	191	2	26459111
Pubmed	The arrhythmogenic human HRC point mutation S96A leads to spontaneous Ca(2+) release due to an impaired ability to buffer store Ca(2+).	RYR2 HRC	3.00e-05	2	191	2	24805197
Pubmed	Hook proteins: association with Alzheimer pathology and regulatory role of hook3 in amyloid beta generation.	MAPT HOOK3	3.00e-05	2	191	2	25799409
Pubmed	VEGFR-3/Flt-4 mediates proliferation and chemotaxis in glial precursor cells.	FLT4 VEGFD	3.00e-05	2	191	2	19646499
Pubmed	DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis.	PAXIP1 TP53BP1	3.00e-05	2	191	2	28475402
Pubmed	Giant cadherins Fat and Dachsous self-bend to organize properly spaced intercellular junctions.	FAT4 DCHS1	3.00e-05	2	191	2	25355906
Pubmed	Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury.	FLT4 VEGFD	3.00e-05	2	191	2	26121315
Pubmed	Ubiquitin ligase NEDD4 promotes the proliferation of hepatocellular carcinoma cells through targeting PCDH17 protein for ubiquitination and degradation.	PCDH17 NEDD4	3.00e-05	2	191	2	38145746
Pubmed	The mouse Fau gene: genomic structure, chromosomal localization, and characterization of two retropseudogenes.	GPI FAU	3.00e-05	2	191	2	7774934
Pubmed	mGrb10 interacts with Nedd4.	GRB10 NEDD4	3.00e-05	2	191	2	10446181
Pubmed	Association between Gene Polymorphisms and Pain Sensitivity Assessed in a Multi-Modal Multi-Tissue Human Experimental Model - An Explorative Study.	COMT OPRK1	3.00e-05	2	191	2	27061127
Pubmed	Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.	FLT4 VEGFD	3.00e-05	2	191	2	26476536
Pubmed	The polycystic kidney disease-related proteins Bicc1 and SamCystin interact.	ANKS6 BICC1	3.00e-05	2	191	2	19324013
Pubmed	VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma.	FLT4 VEGFD	3.00e-05	2	191	2	18338756
Pubmed	A genomic sequence analysis of the mouse and human microtubule-associated protein tau.	MAPT KANSL1	3.00e-05	2	191	2	11641718
Pubmed	Functional local crosstalk of inositol 1,4,5-trisphosphate receptor- and ryanodine receptor-dependent Ca2+ release in atrial cardiomyocytes.	RYR2 ITPR2	3.00e-05	2	191	2	28158491
Pubmed	Serum level of VEGF-D in patients with primary lymphedema.	FLT4 VEGFD	3.00e-05	2	191	2	15693535
Pubmed	Structure of the planar cell polarity cadherins Fat4 and Dachsous1.	FAT4 DCHS1	3.00e-05	2	191	2	36797229
Pubmed	Mammalian cadherins DCHS1-FAT4 affect functional cerebral architecture.	FAT4 DCHS1	3.00e-05	2	191	2	25930014
Pubmed	VEGF-D promotes pulmonary oedema in hyperoxic acute lung injury.	FLT4 VEGFD	3.00e-05	2	191	2	26924464
Pubmed	Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis.	IGFBP1 IGFBP2	3.00e-05	2	191	2	27215343
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CAD MAP1A WDR7 SYNE1 SPTAN1 DBN1 LRCH1 ZNF512B EEF2 FAU SAFB NRXN2 USP42 RRP12 MACF1 CHD6 SPEN ALPG	3.23e-05	1082	191	18	38697112
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	MAP1A MAPT SPTAN1 NEDD4 EEF2 PTPRZ1 PRRT3 MACF1	4.48e-05	231	191	8	16452087
Pubmed	Global gene expression analysis of murine limb development.	DMTF1 CBL DMRT2 ZFHX4 PKNOX1 VEGFD	4.78e-05	117	191	6	22174793
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	SYNE1 SPTAN1 RNF40 KANSL1 MACF1 HERC2	5.51e-05	120	191	6	31413325
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	FAT4 WDR64 DRP2 LRRC37A3 NR4A3 TBC1D25 NBEA CBL RYR2 ASXL3 PAXIP1 CHD6 SPEN	5.73e-05	638	191	13	31182584
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	GPI CAD WARS1 COMT RASA3 POLD1 SPTAN1 EEF2 FAU SAFB KANSL1 BAZ2A MICAL2 TLN1 RRP12 MACF1 HERC2 PARD3 DHX34 TP53BP1	6.07e-05	1353	191	20	29467282
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	STRN3 ARHGEF12 LRCH1 HOOK3 FAM120C LRCH4	6.92e-05	125	191	6	29467281
Pubmed	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	RYR2 KCNE4 PARD3	7.07e-05	15	191	3	19684603
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	CASP8AP2 FAT4 CAD WARS1 WDR7 SYNE1 SPTAN1 LENG1 RNF40 ZNF512B DCHS1 CHD6 TASOR PCDH9	8.01e-05	754	191	14	35906200
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	NUSAP1 STRN3 CAD POLD1 SYNE1 CDKN2AIP PIEZO1 ARHGEF12 BAZ2A FGD4 FAM120C CRACDL TLN1 RRP12 LRCH4 MACF1 CHD6 HERC2 PARD3 SPEN TASOR	8.27e-05	1497	191	21	31527615
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	GRB10 MADD NRXN2 RRP12 MACF1 TASOR	8.60e-05	130	191	6	12421765
Pubmed	Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice.	WDR7 ASH1L ZFHX4	8.66e-05	16	191	3	16096065
Pubmed	Cell surface flip-flop of phosphatidylserine is critical for PIEZO1-mediated myotube formation.	MYF5 PIEZO1	8.97e-05	3	191	2	29799007
Pubmed	High interstitial fluid pressure promotes tumor progression through inducing lymphatic metastasis-related protein expressions in oral squamous cell carcinoma.	FLT4 VEGFD	8.97e-05	3	191	2	24085575
Pubmed	Unc5B associates with LARG to mediate the action of repulsive guidance molecule.	UNC5B ARHGEF12	8.97e-05	3	191	2	19273616
Pubmed	Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.	FLT4 VEGFD	8.97e-05	3	191	2	28791841
Pubmed	Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.	MAPT KANSL1	8.97e-05	3	191	2	18509094
Pubmed	Nedd4 controls animal growth by regulating IGF-1 signaling.	GRB10 NEDD4	8.97e-05	3	191	2	18812566
Pubmed	Feedback regulation of DUSP6 transcription responding to MAPK1 via ETS2 in human cells.	DUSP6 ETS2	8.97e-05	3	191	2	18848526
Pubmed	Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology.	MAPT KANSL1	8.97e-05	3	191	2	26949217
Pubmed	The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man.	FLT4 VEGFD	8.97e-05	3	191	2	11279005
Pubmed	Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.	FLT4 VEGFD	8.97e-05	3	191	2	18561194
Pubmed	Sex-Specific Control of Muscle Mass: Elevated IGFBP Proteolysis and Reductions of IGF-1 Levels Are Associated with Substantial Loss of Carcass Weight in Male DU6PxIGFBP-2 Transgenic Mice.	IGFBP1 IGFBP2	8.97e-05	3	191	2	32993096
Pubmed	The role of the VEGF-C/-D/flt-4 autocrine loop in the pathogenesis of salivary neoplasms.	FLT4 VEGFD	8.97e-05	3	191	2	22326635
Pubmed	p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl.	CBL TLN1	8.97e-05	3	191	2	8641358
Pubmed	Effects of acute exercise, exercise training, and diabetes on the expression of lymphangiogenic growth factors and lymphatic vessels in skeletal muscle.	FLT4 VEGFD	8.97e-05	3	191	2	17766486
Pubmed	Vascular endothelial growth factor D is dispensable for development of the lymphatic system.	FLT4 VEGFD	8.97e-05	3	191	2	15743836
Pubmed	Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.	FLT4 VEGFD	8.97e-05	3	191	2	21481239
Pubmed	Immunohistochemical analysis of insulin-like growth factor-binding proteins -1, -2, and -3 in implantation sites of the mouse.	IGFBP1 IGFBP2	8.97e-05	3	191	2	9785199
Pubmed	Role of protein phosphatase 2A in the regulation of endothelial cell cytoskeleton structure.	MAPT SAFB	8.97e-05	3	191	2	16475161
Pubmed	Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysis.	FLT4 VEGFD	8.97e-05	3	191	2	11574540
Pubmed	Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).	FLT4 VEGFD	8.97e-05	3	191	2	9435229
Pubmed	Ablation of HRC alleviates cardiac arrhythmia and improves abnormal Ca handling in CASQ2 knockout mice prone to CPVT.	RYR2 HRC	8.97e-05	3	191	2	26410369
Pubmed	APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.	COMT MAPT	8.97e-05	3	191	2	27061069
Pubmed	Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines.	FLT4 VEGFD	8.97e-05	3	191	2	19301310
Pubmed	The mechanosensitive ion channel PIEZO1 is expressed in tendons and regulates physical performance.	MYF5 PIEZO1	8.97e-05	3	191	2	35648809
Pubmed	Genetic Variations of OPRM1, OPRK1, and COMT Genes and Their Possible Associations with Oral Pain in a Population from Argentina.	COMT OPRK1	8.97e-05	3	191	2	30365572
Pubmed	The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor.	GRB10 NEDD4	8.97e-05	3	191	2	12697834
Pubmed	Ryanodine Receptor 2 Contributes to Impaired Protein Localization in Cyclic Nucleotide-Gated Channel Deficiency.	NRL RYR2	8.97e-05	3	191	2	31182474
Pubmed	Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas.	FLT4 VEGFD	8.97e-05	3	191	2	17926187
Pubmed	OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study.	COMT OPRK1	8.97e-05	3	191	2	31806881
Pubmed	Structural basis for the interaction between the growth factor-binding protein GRB10 and the E3 ubiquitin ligase NEDD4.	GRB10 NEDD4	8.97e-05	3	191	2	20980250
Cytoband	8q11.2	OPRK1 ATP6V1H	1.03e-04	4	191	2	8q11.2
GeneFamily	Non-clustered protocadherins	PCDH12 PCDH17 PCDH9	6.16e-05	12	121	3	21
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	DRP2 HERC2 NBR1	2.22e-04	18	121	3	91
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	DMTF1 BDP1 CHD6 CRAMP1	4.34e-04	53	121	4	532
GeneFamily	Insulin like growth factor binding proteins	IGFBP1 IGFBP2	6.55e-04	6	121	2	1065
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	OBSCN ARHGEF12 FGD4 ARHGEF26	9.99e-04	66	121	4	722
GeneFamily	BEN domain containing	NACC2 BANP	1.55e-03	9	121	2	422
Coexpression	GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	FAT4 CAD POLD1 SYNE1 PEX26 EEF2 ACSM3 MICAL2 LRCH4 DCTPP1	1.89e-06	196	191	10	M5557
Coexpression	GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	ACAP1 STK17A SYNE1 SPTAN1 BAZ2A MACF1 USPL1 ZNF839 TASOR S100PBP	2.16e-06	199	191	10	M7607
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	DMTF1 BDP1 ACAP1 PHF20 STK17A SYNE1 PIEZO1 SPTAN1 DUSP6 ASH1L BIRC3 CBL APOBR ITPR2 SLC5A3 FAU KANSL1 TBRG1 USP42 SASH3 TLN1 MACF1 RNF216 PARP9 USF2 SPEN TASOR	1.19e-05	1492	191	27	M40023
Coexpression	GSE23695_CD57_POS_VS_NEG_NK_CELL_UP	DMTF1 STRN3 SLC29A3 PHF20 RASA3 DUSP6 SPC25 RREB1 MADD	1.64e-05	199	191	9	M7784
Coexpression	GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN	NUSAP1 WDR7 ITPR2 EEF2 KANSL1 MEGF9 TM2D2 NACC2 ZNF839	1.71e-05	200	191	9	M8651
Coexpression	IRITANI_MAD1_TARGETS_DN	GPI CAD POLD1 EEF2 DCTPP1	1.88e-05	45	191	5	MM1263
Coexpression	IRITANI_MAD1_TARGETS_DN	GPI CAD POLD1 EEF2 DCTPP1	2.10e-05	46	191	5	M1944
ToppCell	droplet-Kidney-nan-3m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NID2 MAP1A COL20A1 PCDHGA5 CRTAC1 INKA2 IGFBP2 ZFHX4 PTPRZ1 NAV3	6.47e-09	181	191	10	0b1e7335648823b1d83bdfa878ccd44efe7bba9a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FAT4 SPTAN1 ASH1L ARHGEF12 PCDH12 PCDH17 NEDD4 AGO4 MACF1 FOXP1	1.68e-08	200	191	10	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL20A1 DUSP6 NBEA PCDH17 IGFBP2 FGD4 PTPRZ1 CHD6 PCDH9	1.23e-07	187	191	9	dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NID2 HSPG2 FLT4 COL11A2 UNC5B NEXMIF SLC19A3 NRXN2 NAV3	1.40e-07	190	191	9	f50b9814a1beac67dc042a8c27dfd085ceeda3a6
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NID2 HSPG2 FLT4 COL11A2 UNC5B NEXMIF SLC19A3 NRXN2 NAV3	1.40e-07	190	191	9	a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NID2 HSPG2 FLT4 COL11A2 UNC5B NEXMIF SLC19A3 NRXN2 NAV3	1.40e-07	190	191	9	57c136bf6d7feafb4a220877bed0cc8fdf314db2
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAPT COL20A1 DUSP6 NBEA PCDH17 GPR83 NRXN2 PTPRZ1 PCDH9	2.17e-07	200	191	9	553e9612874480f4d2a45671462e266cd0a09321
ToppCell	Children_(3_yrs)-Epithelial-basal_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FHOD3 PCDH17 GRIP1 EFNA5 IGFBP2 DMRT2 PTPRZ1 ASXL3	1.05e-06	178	191	8	fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 COL11A2 ZCWPW1 MAP1A COL20A1 ZFHX4 MEGF9 PTPRZ1	1.24e-06	182	191	8	a1c0e4090a9e7aa4941a40c817d178de144888b6
ToppCell	droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NID2 FLT4 COL11A2 UNC5B NEXMIF SLC19A3 NRXN2 NAV3	1.40e-06	185	191	8	3a4ae836e882e8d29eb0a2dfab5677f10f2d365f
ToppCell	droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NID2 FLT4 COL11A2 UNC5B NEXMIF SLC19A3 NRXN2 NAV3	1.40e-06	185	191	8	224f0b022c21dd40bf1f7503f00b3107ef958975
ToppCell	facs-Limb_Muscle\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYF5 DRP2 BIRC3 NR4A3 BCL3 JSRP1 ZFHX4 RTL1	1.64e-06	189	191	8	21ec43859d21ffc565acbe36489da1d2d0f9877d
ToppCell	Non-neuronal-Non-dividing-OPC-OPC\|World / Primary Cells by Cluster	COL20A1 DUSP6 INKA2 PCDH17 MAP3K1 ITPR2 PTPRZ1 PCDH9	1.64e-06	189	191	8	ddf5be73912570c32c50f4ac2902da9b590526f8
ToppCell	Non-neuronal-Non-dividing-OPC\|World / Primary Cells by Cluster	COL20A1 DUSP6 INKA2 PCDH17 MAP3K1 ITPR2 PTPRZ1 PCDH9	1.64e-06	189	191	8	13848a031ab896b4b24c8319e4745b9b17ff9cfd
ToppCell	Non-neuronal-Non-dividing-OPC-OPC-30\|World / Primary Cells by Cluster	COL20A1 DUSP6 INKA2 PCDH17 MAP3K1 ITPR2 PTPRZ1 PCDH9	1.64e-06	189	191	8	313d165fad541ec6e8dd524b88856e2c93eeb681
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL20A1 NBEA PCDH17 IGFBP2 FGD4 PTPRZ1 CHD6 PCDH9	1.78e-06	191	191	8	a53616c84178eb6c29b48662358765b082df3f97
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ASH1L GRB10 FHOD3 FGD4 MACF1 FOXP1 PARD3 BICC1	1.85e-06	192	191	8	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 FLT4 UNC5B ARHGEF12 PCDH12 PCDH17 NEDD4 IGFBP2	1.92e-06	193	191	8	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 FLT4 UNC5B ARHGEF12 PCDH12 PCDH17 NEDD4 IGFBP2	1.92e-06	193	191	8	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	CV-Severe-6\|Severe / Virus stimulation, Condition and Cluster	IL12RB1 SPTAN1 BIRC3 MAP3K6 TBRG1 TLN1 FOXP1 PARP9	2.00e-06	194	191	8	d33be6ed1de907aeea0c2dce09796556b8efdd4e
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	OBSCN ETS2 FHOD3 GRIP1 EFNA5 IGFBP2 PTPRZ1 ASXL3	2.08e-06	195	191	8	6c9c58322c1df891bb4bab56dacb542c8777bb7d
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Stem_cells\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	FAM13C CRTAC1 NBEA EFNA5 FOXP1 MGARP ARHGEF26 VEGFD	2.08e-06	195	191	8	2fa0216ba493d9722324c0a9a0c59c40e72b3c4e
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Stem_cells-retina_progenitors\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	FAM13C CRTAC1 NBEA EFNA5 FOXP1 MGARP ARHGEF26 VEGFD	2.08e-06	195	191	8	06a437459717dc3c41ec343b1ec57cf910ecbdd8
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	LRRC37A3 NBEA ITPR2 GRIP1 EFNA5 KANSL1 FGD4 PARD3	2.41e-06	199	191	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	FAT4 SPTAN1 ETS2 ARHGEF12 PCDH12 PCDH17 MACF1 FOXP1	2.51e-06	200	191	8	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLT4 SPTAN1 ETS2 ARHGEF12 PCDH12 PCDH17 NEDD4 MACF1	2.51e-06	200	191	8	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FLT4 WARS1 ETS2 PCDH12 MAP3K6 PCDH17 DCHS1	2.51e-06	200	191	8	ced14d83222dbebca85c40540e76824e683354f3
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FAT4 SPTAN1 ETS2 ARHGEF12 PCDH12 PCDH17 MACF1 FOXP1	2.51e-06	200	191	8	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	BAL-Mild-cDC_5\|Mild / Compartment, Disease Groups and Clusters	MAP1A IFT172 NPHP4 SLC5A3 LRRC37A VNN1 DHX34	6.25e-06	161	191	7	7a6e8ed0b5d999efce8945d8083ab01d71be9a92
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-3\|TCGA-Colorectal / Sample_Type by Project: Shred V9	RAB11B COMT POLD1 ZNF668 BANP USF2 WDR24	7.06e-06	164	191	7	201aee6387e69f918d87fa87d9b5b2ab3b305f61
ToppCell	wk_20-22-Hematologic-Myeloid-GMP\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	DAGLB GPI RREB1 CDH24 LRRC37A MLC1 PRRT3	7.64e-06	166	191	7	d96e88e73a40205f32cebd7e54ca1ff09ee1e7e8
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ACAP1 NRL PIEZO1 LRRC37A2 LRCH4 ARHGEF26 TP53BP1	8.59e-06	169	191	7	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ACAP1 NRL PIEZO1 LRRC37A2 LRCH4 ARHGEF26 TP53BP1	8.59e-06	169	191	7	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	CV-Healthy-4\|Healthy / Virus stimulation, Condition and Cluster	GPI FLT4 DUSP6 NR4A3 DBN1 IGFBP2 KIAA1958	1.04e-05	174	191	7	26544cc5f51cb4dc1251e62d9f80b6c956194d38
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAM13C ITPR2 GRIP1 EFNA5 DMRT2 FOXP1 VWA5B1	1.08e-05	175	191	7	77c16e615c0fb9c83f29d7e0a547be72635fac81
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CASP8AP2 ZCWPW1 EFNA5 LRCH4 MACF1 DCTPP1 VEGFD	1.12e-05	176	191	7	d30241fb8119834d6e7b59efec3f92fc7a3d1247
ToppCell	metastatic_Brain-Fibroblasts-Undetermined\|metastatic_Brain / Location, Cell class and cell subclass	NID2 GARNL3 MAP1A SUCLA2 IGFBP2 ZFHX4 PCDH9	1.16e-05	177	191	7	54f39be5d90363cfd44dea1a96ae06d3143aa795
ToppCell	Control-T/NK-NK\|Control / Disease group,lineage and cell class （2021.01.30）	ACAP1 PCDHGA5 DBN1 SLC5A3 SALL2 MLC1 PCDH9	1.20e-05	178	191	7	079fd19bdeed86bf985c4083af432432d66ad546
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FAM13C ITPR2 GRIP1 EFNA5 DMRT2 FOXP1 VWA5B1	1.25e-05	179	191	7	e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FLT4 FAM13C GRB10 PCDH17 NAV3 DCHS1	1.25e-05	179	191	7	8f9e538c822940785130297712b75131812a4603
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FLT4 GRB10 PCDH12 PCDH17 EEF2 DCTPP1	1.29e-05	180	191	7	16728b9a1c52097e3a460534be71a476ecc54f0f
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	NRAP OBSCN FHOD3 RYR2 EFNA5 RNF216 PCDH9	1.39e-05	182	191	7	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL12RB1 ACAP1 STK17A BIRC3 APOBR SASH3 CRACDL	1.44e-05	183	191	7	c7fedb5b0c1f17b3391ce1c4a6bfca7615c359c5
ToppCell	COVID-19-Heart-CM_4\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRAP NR4A3 FHOD3 JAKMIP3 RYR2 EFNA5 PCDH9	1.44e-05	183	191	7	2902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCell	COVID-19-kidney-Mito-rich_EC\|kidney / Disease (COVID-19 only), tissue and cell type	FLT4 UNC5B SYNE1 GRB10 MAP3K6 PCDH17 NAV3	1.44e-05	183	191	7	3c4153479fc4ab2d073d92cee120480015555914
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 DRP2 OBSCN RYR2 ZFHX4 ASXL3 NAV3	1.49e-05	184	191	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 DRP2 OBSCN RYR2 ZFHX4 ASXL3 NAV3	1.49e-05	184	191	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 DRP2 OBSCN RYR2 ZFHX4 ASXL3 NAV3	1.49e-05	184	191	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRAP OBSCN FHOD3 RYR2 PPP1R3A EFNA5 PCDH9	1.55e-05	185	191	7	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	droplet-Lung-LUNG-1m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRP2 NEXMIF JSRP1 INKA2 TUFT1 MLC1 PARD3	1.60e-05	186	191	7	e52cf44989c57c433bf82e9fa13b4643e88f3577
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	UNC5B EFNA5 ZFHX4 NAV3 HRC MGARP PCDH9	1.60e-05	186	191	7	8915436d09775f2828a7678af203b1082b36e21c
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 MAPT PCDH12 ZNF668 SALL2 NRXN2 DCHS1	1.60e-05	186	191	7	90d53c2597a9f3a2b39afba75adfc54f1ca0a4db
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NID2 ABAT FLT4 UNC5B NBEA NRXN2 NAV3	1.60e-05	186	191	7	0de87109da9324c597fadf2eb782f0f158afe832
ToppCell	droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NID2 ABAT FLT4 UNC5B NBEA NRXN2 NAV3	1.60e-05	186	191	7	f23f21781a758541f59c06efa7739d26a03fb478
ToppCell	droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRP2 NEXMIF JSRP1 INKA2 TUFT1 MLC1 PARD3	1.60e-05	186	191	7	4c0b59d845b79323e7a3287e7c4d249f5f322556
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 MAPT PCDH12 ZNF668 SALL2 NRXN2 DCHS1	1.60e-05	186	191	7	2cae34336f184f971f7c8684cc27c23a4e7369ed
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FLT4 WARS1 GRB10 PCDH12 PCDH17 NAV3	1.66e-05	187	191	7	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT4 UNC5B DUSP6 PCDH12 PCDH17 NEDD4 IGFBP2	1.71e-05	188	191	7	73f6ec915934154f435a376cb274b058ff7c5f35
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FAM13C ITPR2 EFNA5 DMRT2 FGD4 FOXP1 VWA5B1	1.71e-05	188	191	7	e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZCWPW1 DRP2 MAPT TBC1D25 IKZF5 NAV3 ZNF839	1.71e-05	188	191	7	c2febf9fd4632af1f922067c3a30e5c50f75f480
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKNAD1 BIRC3 ANKLE1 TUFT1 MAST1 TMEM102 VWA2	1.77e-05	189	191	7	6f0fc5271a7d3682f145e734abc3be6473dda2e2
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKNAD1 BIRC3 ANKLE1 TUFT1 MAST1 TMEM102 VWA2	1.77e-05	189	191	7	3b9ce8964b16cb2200d30cbb0bfc711dcad2380e
ToppCell	critical-Epithelial-Ionocyte\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FAM13C MAPT DBN1 ITPR2 DMRT2 MEGF9 NAV3	1.83e-05	190	191	7	05a2c3549b68f49081723bf35db14974274419d5
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-Neuroblast\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL20A1 STK17A DUSP6 PCDH17 IGFBP2 PTPRZ1 CHD6	1.83e-05	190	191	7	5a82709eeb68df4563bb42b97636d110126d2f97
ToppCell	wk_08-11-Epithelial-PNS-Schwann_precursor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	COL20A1 PCDH17 GPR83 IGFBP2 NRXN2 PTPRZ1 PCDH9	1.83e-05	190	191	7	4a777d8aa19cadd3b61b023772df142421a89113
ToppCell	facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRAP MAPT OBSCN FHOD3 RYR2 PPP1R3A HRC	1.90e-05	191	191	7	9d7d680da3979e256191b534ebd14c5383e0cf93
ToppCell	facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRAP MAPT OBSCN FHOD3 RYR2 PPP1R3A HRC	1.90e-05	191	191	7	543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	HSPG2 WARS1 SYNE1 SPC25 GRB10 PCDH17 CRACDL	1.90e-05	191	191	7	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	facs-Diaphragm\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYF5 DRP2 BIRC3 NR4A3 BCL3 JSRP1 ZFHX4	1.96e-05	192	191	7	486cbf9791ca619e307e8b18aa70ce22111f4f26
ToppCell	droplet-Heart-HEART-1m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 DUSP6 ETS2 PCDH12 PCDH17 KCNA5 NAV3	1.96e-05	192	191	7	9da21ce330f3b5661f159cf18d1c3e5ccc11d6dd
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FAT4 FLT4 MAPT PCDH12 PCDH17 PPP1R3A	2.03e-05	193	191	7	826b8dd801298b3e0cd76232feae5a14026b8806
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FAT4 FLT4 MAPT PCDH12 PCDH17 PPP1R3A	2.03e-05	193	191	7	87d3a577d37fb0cb4b6313c596310de452bc3872
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FAT4 FLT4 MAPT PCDH12 PCDH17 PPP1R3A	2.03e-05	193	191	7	d485634c564b268e344b6a2863c26f6adaec9e38
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SYNE1 CRTAC1 EFNA5 MICAL2 PARD3 FAM20A PCDH9	2.03e-05	193	191	7	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SYNE1 CRTAC1 EFNA5 MICAL2 PARD3 FAM20A PCDH9	2.03e-05	193	191	7	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	NRAP OBSCN FHOD3 RYR2 EFNA5 RNF216 PCDH9	2.03e-05	193	191	7	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FHOD3 GRIP1 EFNA5 FGD4 KIAA1958 PARD3 BICC1	2.03e-05	193	191	7	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 UNC5B ARHGEF12 PCDH12 PCDH17 NEDD4 IGFBP2	2.10e-05	194	191	7	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FHOD3 GRIP1 EFNA5 FGD4 KIAA1958 PARD3 BICC1	2.10e-05	194	191	7	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 UNC5B ARHGEF12 PCDH12 PCDH17 NEDD4 IGFBP2	2.10e-05	194	191	7	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FLT4 SYNE1 ETS2 GRB10 PCDH17 NAV3	2.10e-05	194	191	7	a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FHOD3 GRIP1 EFNA5 FGD4 KIAA1958 PARD3 BICC1	2.10e-05	194	191	7	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-J_(Lipofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	DUSP6 BIRC3 INKA2 IGFBP1 IGFBP2 LRCH4 FAM20A	2.10e-05	194	191	7	784b15119c91ace33d34bfb3d68c182566a3e9a8
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	NRL PIEZO1 LRRC37A2 LRCH4 ARHGEF26 PCDH9 TP53BP1	2.10e-05	194	191	7	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 SYNE1 SPC25 ETS2 PCDH12 NEDD4 KCNE4	2.10e-05	194	191	7	ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	NRL PIEZO1 LRRC37A2 LRCH4 ARHGEF26 PCDH9 TP53BP1	2.10e-05	194	191	7	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FLT4 UNC5B ETS2 GRB10 KCNE4 NAV3	2.10e-05	194	191	7	e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	MYF5 NID2 MAP1A PCDH12 KCNE4 HRC BICC1	2.10e-05	194	191	7	55b97095a7a17a312c616703d291738a0f806339
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	HSPG2 FLT4 ETS2 GRB10 PCDH12 PCDH17 MACF1	2.17e-05	195	191	7	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	COVID-19_Severe\|World / Disease condition and Cell class	STK17A SYNE1 ETS2 IGFBP2 MEGF9 TLN1 FAM20A	2.17e-05	195	191	7	22f56ccb81967bff54a1f90e949a8dfc2ce0e4ab
ToppCell	10x5'\|World / Manually curated celltypes from each tissue	GPI STK17A NR4A3 EEF2 TBRG1 SASH3 RRP12	2.17e-05	195	191	7	de28b998793271c4f69ce9e183c3e62d809e9cc8
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NUSAP1 COL20A1 DUSP6 SPC25 PCDH17 IGFBP2 PTPRZ1	2.24e-05	196	191	7	4924a36a81d62863c1004b8c76f8096a1f89c548
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT4 WARS1 SYNE1 ARHGEF12 PCDH12 PCDH17 NEDD4	2.24e-05	196	191	7	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	HSPG2 FLT4 DUSP6 ETS2 GRB10 PCDH12 PCDH17	2.24e-05	196	191	7	b71b197cb92117dd9efaa13de000841901cc4ca8
ToppCell	COVID_non-vent-Lymphocytic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ACAP1 STK17A SYNE1 SPTAN1 BIRC3 MACF1 FOXP1	2.31e-05	197	191	7	c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FHOD3 GRIP1 EFNA5 FGD4 PARD3 FAM20A BICC1	2.31e-05	197	191	7	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DAGLB DUSP6 ETS2 NR4A3 ITPR2 SASH3 FGD4	2.31e-05	197	191	7	b597c292fc1cb381a4325fed15a32966c38def28
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ETS2 FHOD3 GRIP1 EFNA5 IGFBP2 PTPRZ1 ASXL3	2.31e-05	197	191	7	107cb153ea7fc74bbd244dbb9d0499c0a8506724
ToppCell	AT2_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	HSPG2 SYNE1 DUSP6 BCL3 PTK7 MICAL2 FAM20A	2.31e-05	197	191	7	42e49a8ce3118db6c2fd620d70c480b75143c828
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NID2 HSPG2 FLT4 UNC5B GRB10 PCDH12 IGFBP1	2.31e-05	197	191	7	9244f087ba4b60fdc81d54ce91860de715b3e12c
Drug	Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A	MAPT PCDH12 MAP3K6 MAP3K1 ZNF668 SALL2 EFNA5 R3HCC1L PKNOX1 RNF216	5.90e-06	194	191	10	6778_DN
Drug	Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	MAPT SYNE1 ASH1L ZNF512B AGO4 BAZ2A NAV3 USF2 ZNF839 ARHGEF26	6.46e-06	196	191	10	6619_DN
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	HSPG2 RAB11B COMT UNC5B ETS2 MAP3K1 ITPR2 ZNF668 RNF216 ARHGEF26	6.76e-06	197	191	10	6773_DN
Drug	Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	RAB11B ZCWPW1 PCDH12 CBL MAP3K1 SALL2 PARD3 USF2 DHX34 PCDH9	6.76e-06	197	191	10	6787_DN
Drug	Theobromine [83-67-0]; Down 200; 22.2uM; MCF7; HT_HG-U133A	RAB11B MAPT GRB10 CBL PEX26 IKZF5 ZNF668 SAFB PKNOX1 PCDH9	7.07e-06	198	191	10	4958_DN
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; HL60; HG-U133A	ACAP1 DRP2 COMT ARHGEF12 BCL3 SALL2 BAZ2A RRP12 USF2 BICC1	7.07e-06	198	191	10	1411_UP
Drug	alpha-estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A	TRAF3IP2 STRN3 SYNE1 SPTAN1 PEX26 ACSM3 NACC2 BAZ2A PKNOX1 RNF216	7.39e-06	199	191	10	1210_DN
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A	MAPT ARHGEF12 NPHP4 SLC5A3 ZNF668 SAFB TLN1 USF2 ZNF839 TP53BP1	7.39e-06	199	191	10	5283_DN
Drug	2-Chloropyrazine [14508-49-7]; Down 200; 35uM; HL60; HT_HG-U133A	IL12RB1 RAB11B SLC29A3 UNC5B BIRC3 TUFT1 MAP3K1 IKZF5 SALL2 MACF1	7.39e-06	199	191	10	6148_DN
Drug	honokiol	FLT4 SYNE1 GRB10 MAP3K1 PTK7 VEGFD	9.08e-06	58	191	6	CID000072303
Drug	Fenbendazole [43210-67-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A	MYF5 RAB11B COMT MCPH1 MAP1A ETS2 BIRC3 SPEN PCDH9	3.39e-05	190	191	9	3888_UP
Drug	Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A	ZCWPW1 SYNE1 SPTAN1 DUSP6 ARHGEF12 BAZ2A PKNOX1 RNF216 USF2	3.68e-05	192	191	9	7104_DN
Drug	Securinine [5610-40-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A	RAB11B SPTAN1 ETS2 ARHGEF12 LRCH1 INKA2 RRP12 MACF1 DHX34	3.68e-05	192	191	9	3470_UP
Drug	Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A	RAB11B STRN3 COMT ETS2 PEX26 ZFHX4 BAZ2A PKNOX1 PCDH9	3.68e-05	192	191	9	3375_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A	TRAF3IP2 NID2 HSPG2 RAB11B PHF20 R3HCC1L BAZ2A TLN1 USF2	3.84e-05	193	191	9	4338_DN
Drug	pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A	PHF20 MAP1A GRB10 DBN1 INKA2 RYR2 ITPR2 TOX4 PKNOX1	3.99e-05	194	191	9	7523_UP
Drug	paclitaxel; Down 200; 0.1uM; MCF7; HG-U133A	DRP2 NPHP4 ZNF668 BAZ2A RRP12 PARD3 USF2 ZNF839 DHX34	3.99e-05	194	191	9	640_DN
Drug	5666823; Down 200; 100uM; MCF7; HG-U133A	DRP2 PHF20 ARHGEF12 IKZF5 ZFHX4 PKNOX1 USF2 DHX34 TP53BP1	4.16e-05	195	191	9	609_DN
Drug	17-AAG; Down 200; 1uM; SKMEL5; HG-U133A	CDKN2AIP DUSP6 NR4A3 BCL3 ZNF512B BAZ2A RRP12 USF2 PCDH9	4.16e-05	195	191	9	505_DN
Drug	15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A	PHF20 BCL3 LRCH1 MAP3K6 ITPR2 ZNF512B BAZ2A ZNF839 DHX34	4.16e-05	195	191	9	5591_DN
Drug	Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; HL60; HT_HG-U133A	HSPG2 STRN3 SLC29A3 SYNE1 BIRC3 NR4A3 ZNF512B MEGF9 BAZ2A	4.16e-05	195	191	9	2901_DN
Drug	Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A	ASH1L ETS2 DBN1 ZNF668 MEGF9 BAZ2A PKNOX1 USF2 ZNF839	4.33e-05	196	191	9	7228_DN
Drug	fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	TRAF3IP2 IL12RB1 NID2 PHF20 PTK7 MICAL2 RRP12 USF2 DHX34	4.50e-05	197	191	9	4461_DN
Drug	Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; HL60; HT_HG-U133A	TRAF3IP2 ACAP1 SPTAN1 ARHGEF12 ZNF668 MACF1 OSGIN2 USF2 ZNF839	4.50e-05	197	191	9	2343_DN
Drug	Probucol [23288-49-5]; Down 200; 7.8uM; PC3; HT_HG-U133A	ZCWPW1 MAPT PCDH12 RYR2 SLC5A3 ZNF668 FAM120C MICAL2 ZNF839	4.50e-05	197	191	9	4666_DN
Drug	Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	MYF5 RAB11B RASA3 MAPT STK17A SPTAN1 GRB10 BIRC3 PKNOX1	4.50e-05	197	191	9	4974_DN
Drug	Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HT_HG-U133A	HSPG2 STRN3 MIA3 ZCWPW1 SPTAN1 ARHGEF12 IKZF5 ZNF668 ZNF839	4.50e-05	197	191	9	4216_DN
Drug	Quinic acid [86-68-0]; Up 200; 19.6uM; PC3; HT_HG-U133A	DRP2 PHF20 SYNE1 SPTAN1 BIRC3 AGO4 RRP12 PKNOX1 USF2	4.68e-05	198	191	9	7317_UP
Drug	Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	TRAF3IP2 GRB10 LRCH1 PEX26 ITPR2 BANP USF2 DHX34 PCDH9	4.68e-05	198	191	9	7437_DN
Drug	Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; MCF7; HT_HG-U133A	IL12RB1 COMT STK17A ETS2 ARHGEF12 GRB10 CBL BAZ2A FAM120C	4.68e-05	198	191	9	5609_DN
Drug	Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A	ASH1L ARHGEF12 NPHP4 MAP3K6 PEX26 MADD ZNF512B TLN1 ARHGEF26	4.68e-05	198	191	9	1677_DN
Drug	Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; HL60; HT_HG-U133A	IL12RB1 HSPG2 RAB11B FLT4 SYNE1 MAP3K1 ZNF668 FAM120C PKNOX1	4.68e-05	198	191	9	3024_DN
Drug	Chlorogenic acid [327-97-9]; Down 200; 11.2uM; HL60; HT_HG-U133A	TRAF3IP2 COMT NR4A3 RYR2 TOX4 SALL2 PKNOX1 PARD3 ZNF839	4.68e-05	198	191	9	1346_DN
Drug	Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	FLT4 ASH1L GRB10 DBN1 RYR2 MADD SAFB EFNA5 PCDH9	4.87e-05	199	191	9	7330_DN
Drug	Iopamidol [60166-93-0]; Down 200; 5.2uM; HL60; HT_HG-U133A	FLT4 ZCWPW1 PHF20 DBN1 PCDH12 LRCH1 MAP3K1 ITPR2 PCDH9	4.87e-05	199	191	9	2732_DN
Drug	haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A	RAB11B MAPT SPTAN1 ACRV1 DBN1 CBL MLC1 PARD3 DKKL1	5.06e-05	200	191	9	6963_UP
Drug	Elmex protector	GPI ACSM3 SPEN	6.68e-05	10	191	3	CID000123995
Drug	scriptaid; Up 200; 10uM; PC3; HT_HG-U133A	ABAT MAP1A MAPT SPTAN1 CBL TUFT1 MEGF9 PCDH9	1.24e-04	176	191	8	6896_UP
Drug	thioridazine hydrochloride; Up 200; 10uM; PC3; HT_HG-U133A	WARS1 PHF20 BIRC3 IKZF5 BAZ2A VNN1 NAV3 BICC1	1.29e-04	177	191	8	1230_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A	NID2 ABAT MAP1A MAPT ARHGEF12 NBEA TUFT1 PCDH9	1.34e-04	178	191	8	5940_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	MAP1A ETS2 BIRC3 NR4A3 NBEA TUFT1 MEGF9 PCDH9	1.45e-04	180	191	8	6340_UP
Drug	Anisomycin [22862-76-6]; Down 200; 15uM; MCF7; HT_HG-U133A	TRAF3IP2 MAPT SPC25 AHSA1 SLC5A3 SALL2 MEGF9 PCDH9	1.75e-04	185	191	8	5364_DN
Drug	5-iodocytosine	SYNE1 DCTPP1	2.09e-04	3	191	2	CID000014281
Drug	AC1L3G5E	ABAT OPRK1	2.09e-04	3	191	2	CID000114888
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A	STRN3 MIA3 ETS2 MAP3K1 IKZF5 ITPR2 RRP12 PKNOX1	2.10e-04	190	191	8	3966_DN
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	RAB11B SLC29A3 FLT4 RASA3 DUSP6 ARHGEF12 INKA2 USF2	2.17e-04	191	191	8	3387_DN
Drug	Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A	ETS2 MAP3K1 ITPR2 ZNF512B MICAL2 PKNOX1 ARHGEF26 DHX34	2.25e-04	192	191	8	5401_DN
Drug	Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; PC3; HT_HG-U133A	FLT4 MAPT UNC5B ARHGEF12 RYR2 ACSM3 SALL2 RRP12	2.33e-04	193	191	8	6691_DN
Drug	Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A	RAB11B MAP1A MAPT SYNE1 SPTAN1 BIRC3 USF2 DHX34	2.33e-04	193	191	8	4488_DN
Drug	(+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA	STK17A ASH1L ETS2 ARHGEF12 GRB10 NPHP4 PEX26 IKZF5	2.41e-04	194	191	8	954_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A	ZCWPW1 COMT ASH1L APOBR RYR2 PKNOX1 USF2 DHX34	2.41e-04	194	191	8	6199_DN
Drug	Azapropazone [13539-59-8]; Down 200; 13.4uM; HL60; HT_HG-U133A	RAB11B PHF20 NR4A3 TUFT1 SALL2 ZFHX4 BAZ2A DHX34	2.41e-04	194	191	8	3143_DN
Drug	Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A	SYNE1 MAP3K6 IKZF5 IGFBP2 MEGF9 BAZ2A PKNOX1 ZNF839	2.50e-04	195	191	8	7362_DN
Drug	Bromopride [4093-35-0]; Down 200; 11.6uM; PC3; HT_HG-U133A	MAPT SPTAN1 CBL PTK7 USF2 ARHGEF26 DHX34 BICC1	2.50e-04	195	191	8	3719_DN
Drug	Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A	TRAF3IP2 ZCWPW1 MAPT ASH1L ARHGEF12 VNN1 RRP12 NAV3	2.50e-04	195	191	8	6626_DN
Drug	Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; HL60; HG-U133A	TRAF3IP2 ACRV1 ARHGEF12 BCL3 PCDH17 SAFB RRP12 USF2	2.59e-04	196	191	8	1566_UP
Drug	Metyrapone [54-36-4]; Up 200; 17.6uM; HL60; HT_HG-U133A	COMT RASA3 BCL3 PCDH12 ZNF668 KCNA5 PTPRZ1 PKNOX1	2.59e-04	196	191	8	3070_UP
Drug	Allantoin [97-59-6]; Down 200; 25.2uM; MCF7; HT_HG-U133A	FLT4 MAPT GRB10 ZNF512B TLN1 PARD3 USF2 DHX34	2.59e-04	196	191	8	1678_DN
Drug	Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; PC3; HT_HG-U133A	MIA3 PIEZO1 RREB1 PTK7 NEDD4 NACC2 PAXIP1 PKNOX1	2.59e-04	196	191	8	7139_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	STRN3 CDKN2AIP ZNF512B TOX4 SAFB RRP12 PKNOX1 DHX34	2.59e-04	196	191	8	7357_DN
Drug	Brinzolamide [138890-62-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	TRAF3IP2 RAB11B MAPT STK17A DBN1 RYR2 FAM120C DHX34	2.59e-04	196	191	8	5016_DN
Drug	Carisoprodol [78-44-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	MAP1A ETS2 ARHGEF12 MADD IKZF5 PTK7 BAZ2A ZNF839	2.59e-04	196	191	8	6610_DN
Drug	Benzamil hydrochloride [2898-76-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	PHF20 SPTAN1 PCDH12 LRCH1 INKA2 R3HCC1L IGFBP1 RRP12	2.59e-04	196	191	8	3738_UP
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; HL60; HG-U133A	STRN3 POLD1 CDKN2AIP SPC25 DBN1 RRP12 USF2 ZNF839	2.59e-04	196	191	8	1445_DN
Drug	Salbutamol [18559-94-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A	RAB11B COMT STK17A DUSP6 CBL INKA2 ZFHX4 SASH3	2.59e-04	196	191	8	2306_UP
Drug	Sulfaguanidine [57-67-0]; Up 200; 18.6uM; PC3; HT_HG-U133A	ABAT NRL PCDH12 INKA2 PCDH17 KCNA5 DHX34 ALPG	2.59e-04	196	191	8	4257_UP
Drug	Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; HL60; HT_HG-U133A	RAB11B MCPH1 SPTAN1 BIRC3 SALL2 ZFHX4 BAZ2A RNF216	2.68e-04	197	191	8	3127_DN
Drug	Cyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	RAB11B STRN3 MAP1A UNC5B ASH1L IKZF5 ITPR2 ZNF839	2.68e-04	197	191	8	5100_DN
Drug	Ioversol [87771-40-2]; Down 200; 5uM; HL60; HT_HG-U133A	RAB11B ACAP1 COMT RASA3 SPTAN1 DUSP6 ZNF668 ARHGEF26	2.68e-04	197	191	8	3026_DN
Drug	Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; HL60; HT_HG-U133A	STRN3 ABAT PHF20 MCPH1 BIRC3 IKZF5 RRP12 ZNF839	2.68e-04	197	191	8	2934_DN
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A	HSPG2 MAP1A MAPT CBL ZNF668 USF2 ARHGEF26 DHX34	2.68e-04	197	191	8	4295_DN
Drug	Carcinine [56897-53-1]; Up 200; 22uM; MCF7; HT_HG-U133A	FLT4 MIA3 STK17A POLD1 ETS2 CBL RYR2 NOD2	2.68e-04	197	191	8	3242_UP
Drug	haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A	PHF20 UNC5B SPTAN1 CBL R3HCC1L FAM120C PKNOX1 USF2	2.68e-04	197	191	8	7003_UP
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA	DMTF1 ABAT ETS2 GRB10 R3HCC1L USF2 DHX34 PCDH9	2.68e-04	197	191	8	1048_UP
Drug	Niacin [59-67-6]; Down 200; 32.4uM; HL60; HT_HG-U133A	RAB11B FLT4 MCPH1 RASA3 PIEZO1 ZNF668 FAM120C USF2	2.68e-04	197	191	8	3043_DN
Drug	Lovastatin [75330-75-5]; Down 200; 9.8uM; HL60; HT_HG-U133A	FLT4 ZCWPW1 MCPH1 NR4A3 PEX26 ITPR2 NOD2 ZNF512B	2.68e-04	197	191	8	2494_DN
Drug	Myosmine [532-12-7]; Down 200; 27.4uM; MCF7; HT_HG-U133A	RAB11B PHF20 COMT GRB10 BCL3 RYR2 BAZ2A DHX34	2.68e-04	197	191	8	6055_DN
Drug	Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	HSPG2 PHF20 COMT UNC5B CDKN2AIP SPTAN1 TLN1 USF2	2.68e-04	197	191	8	3300_DN
Drug	Pyrithyldione [77-04-3]; Up 200; 24uM; PC3; HT_HG-U133A	DMTF1 FLT4 MAPT SLC5A3 ZNF512B MEGF9 ZNF839 DHX34	2.68e-04	197	191	8	7153_UP
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; HL60; HT_HG-U133A	RAB11B MCPH1 SPTAN1 ASH1L ZNF668 ACSM3 PARD3 DHX34	2.68e-04	197	191	8	2204_DN
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	HSPG2 RAB11B BCL3 SLC5A3 R3HCC1L TLN1 RRP12 PKNOX1	2.68e-04	197	191	8	4336_DN
Drug	AC1N9ZZC	HSPG2 UNC5B OBSCN CBL RYR2 MADD NAV3	2.70e-04	149	191	7	CID004369374
Drug	Air Pollutants	NUSAP1 NID2 SLC29A3 SLC19A3 NBEA ITPR2 SLC5A3 RPS6KC1 GRIP1 ACSM3 HOOK3 AGO4 ZFHX4 MICAL2 NAV3 PARP9 NBR1 PCDH9 TP53BP1	2.72e-04	917	191	19	ctd:D000393
Drug	Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; HL60; HG-U133A	TRAF3IP2 IKZF5 NEDD4 ZNF512B SAFB RRP12 PARD3 USF2	2.77e-04	198	191	8	1743_UP
Drug	Bicuculline (+) [485-49-4]; Down 200; 10.8uM; HL60; HT_HG-U133A	SLC29A3 PHF20 UNC5B PEX26 ITPR2 MICAL2 TLN1 DHX34	2.77e-04	198	191	8	2139_DN
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; HL60; HT_HG-U133A	COMT ARHGEF12 LRCH1 ITPR2 SALL2 MLC1 RNF216 ZNF839	2.77e-04	198	191	8	1300_UP
Drug	cox-2 inhibitor I; Down 200; 10uM; MCF7; HG-U133A	ACRV1 ARHGEF12 NBEA BCL3 SLC5A3 MEGF9 MACF1 DHX34	2.77e-04	198	191	8	612_DN
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; PC3; HT_HG-U133A	PIEZO1 ZNF512B TOX4 TLN1 PKNOX1 RNF216 USF2 ZNF839	2.77e-04	198	191	8	2088_DN
Drug	Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; PC3; HT_HG-U133A	MYF5 RAB11B PCDH12 ITPR2 NOD2 KCNA5 DKKL1 ALPG	2.77e-04	198	191	8	5044_UP
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; PC3; HT_HG-U133A	PHF20 SPTAN1 ARHGEF12 PTK7 R3HCC1L BAZ2A PKNOX1 ZNF839	2.77e-04	198	191	8	5083_DN
Drug	Pinacidil [85371-64-8]; Up 200; 16.4uM; PC3; HT_HG-U133A	RAB11B PHF20 MAPT PCDH17 RYR2 AGO4 MEGF9 DHX34	2.77e-04	198	191	8	6356_UP
Drug	Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; MCF7; HT_HG-U133A	SPTAN1 DBN1 CBL INKA2 ITPR2 SALL2 TLN1 DHX34	2.77e-04	198	191	8	5383_DN
Drug	Amoxapine [14028-44-5]; Down 200; 12.8uM; HL60; HG-U133A	TRAF3IP2 WDR7 RNF40 BAZ2A PKNOX1 MACF1 USF2 TP53BP1	2.77e-04	198	191	8	2013_DN
Drug	Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A	TRAF3IP2 RAB11B COMT DUSP6 BCL3 ZFHX4 BAZ2A FAM120C	2.77e-04	198	191	8	4370_DN
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A	MAPT POLD1 TLN1 PKNOX1 MACF1 USF2 TASOR DHX34	2.77e-04	198	191	8	5345_DN
Drug	Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	FLT4 ZCWPW1 GRB10 ZNF512B PARD3 USF2 ZNF839 DHX34	2.77e-04	198	191	8	3418_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A	RAB11B PHF20 RYR2 ITPR2 BAZ2A RRP12 PKNOX1 DHX34	2.77e-04	198	191	8	3756_DN
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MIA3 PHF20 ARHGEF12 BCL3 CBL MAP3K1 MACF1 DHX34	2.77e-04	198	191	8	4351_DN
Drug	Isradipine [75695-93-1]; Down 200; 10.8uM; HL60; HT_HG-U133A	SLC29A3 PHF20 RASA3 NR4A3 ITPR2 SALL2 MEGF9 DHX34	2.77e-04	198	191	8	3129_DN
Drug	Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A	COMT RASA3 ETS2 GRB10 SALL2 R3HCC1L BAZ2A PCDH9	2.77e-04	198	191	8	6230_UP
Disease	Malignant neoplasm of breast	GPI NID2 ACAP1 WARS1 COMT SYNE1 SPTAN1 LRRC37A2 OBSCN ETS2 JAKMIP3 DBN1 MAP3K6 MAP3K1 NEDD4 PPP1R3A ZNF668 EEF2 HOOK3 LRRC37A KCNA5 MACF1 HERC2 SPEN TP53BP1	2.20e-08	1074	187	25	C0006142
Disease	Van Maldergem Wetzburger Verloes syndrome	FAT4 DCHS1	4.00e-05	2	187	2	C1832390
Disease	Van Maldergem syndrome	FAT4 DCHS1	4.00e-05	2	187	2	cv:C1832390
Disease	Periventricular gray matter heterotopia	FAT4 DCHS1	4.00e-05	2	187	2	C1849173
Disease	brain measurement, neuroimaging measurement	CDKN2AIP SPC25 GRB10 RREB1 LRCH1 MAP3K1 KCNA5 KANSL1 LRCH4 NAV3 MACF1 FOXP1 PARD3	5.35e-05	550	187	13	EFO_0004346, EFO_0004464
Disease	Heterotopia, Periventricular, Autosomal Recessive	FAT4 DCHS1	1.19e-04	3	187	2	C1842563
Disease	heroin dependence (implicated_via_orthology)	ABAT OPRK1	2.38e-04	4	187	2	DOID:9976 (implicated_via_orthology)
Disease	age-related macular degeneration, cataract, glaucoma	PCDHGA5 HERC2	2.38e-04	4	187	2	EFO_0001365, MONDO_0005041, MONDO_0005129
Disease	brain connectivity measurement	STRN3 WARS1 MAPT LRRC37A2 LRCH1 NEDD4 KCNA5 KANSL1 NAV3 FOXP1	2.53e-04	400	187	10	EFO_0005210
Disease	cortical thickness	HSPG2 STRN3 MCPH1 MAPT ARHGEF12 RREB1 LRCH1 PCDH17 MAP3K1 GRIP1 EFNA5 KCNA5 KANSL1 MEGF9 NAV3 MACF1 FOXP1 PARD3	2.71e-04	1113	187	18	EFO_0004840
Disease	body mass index, fasting blood glucose measurement	SPC25 GRB10 RREB1 MADD	3.09e-04	51	187	4	EFO_0004340, EFO_0004465
Disease	Neurodevelopmental Disorders	NEXMIF ASH1L PTK7 ASXL3 FOXP1	3.21e-04	93	187	5	C1535926
Disease	Mucosa-Associated Lymphoid Tissue Lymphoma	BIRC3 FOXP1	3.95e-04	5	187	2	C0242647
Disease	neuroimaging measurement	STRN3 MCPH1 MAPT SPC25 ARHGEF12 GRB10 RREB1 LRCH1 MAP3K1 PTK7 KCNA5 KANSL1 LRCH4 NAV3 MACF1 FOXP1 PARD3	4.86e-04	1069	187	17	EFO_0004346
Disease	cognitive disorder (implicated_via_orthology)	COMT MAPT	5.89e-04	6	187	2	DOID:1561 (implicated_via_orthology)
Disease	Flaccid Muscle Tone	ABAT KANSL1	5.89e-04	6	187	2	C0026825
Disease	Neonatal Hypotonia	ABAT KANSL1	5.89e-04	6	187	2	C2267233
Disease	Muscle Tone Atonic	ABAT KANSL1	5.89e-04	6	187	2	C0427202
Disease	Floppy Muscles	ABAT KANSL1	5.89e-04	6	187	2	C0427201
Disease	Unilateral Hypotonia	ABAT KANSL1	5.89e-04	6	187	2	C0751330
Disease	Cystic kidney	FAT4 ANKS6	5.89e-04	6	187	2	C0022679
Disease	cutaneous melanoma, hair color	RASA3 RREB1 MAP3K1 HERC2	6.54e-04	62	187	4	EFO_0000389, EFO_0003924
Disease	uronyl 2-sulfotransferase measurement	DAGLB NACC2	8.22e-04	7	187	2	EFO_0803240
Disease	age at diagnosis, osteoarthritis	MAPT KANSL1	8.22e-04	7	187	2	EFO_0004918, MONDO_0005178
Disease	Nephronophthisis, familial juvenile	ANKS6 NPHP4	8.22e-04	7	187	2	C1855681
Disease	LDL cholesterol change measurement, response to simvastatin, response to fenofibrate	FOXP1 BICC1	1.09e-03	8	187	2	EFO_0007804, GO_1901557, GO_1903491
Disease	Nephronophthisis	IFT172 NPHP4	1.40e-03	9	187	2	cv:C0687120
Disease	22q11 partial monosomy syndrome	COMT RREB1	1.40e-03	9	187	2	C3266101
Disease	Polycystic Kidney, Autosomal Dominant	ANKS6 BICC1	1.40e-03	9	187	2	C0085413
Disease	cystic kidney disease (implicated_via_orthology)	IFT172 BICC1	1.74e-03	10	187	2	DOID:2975 (implicated_via_orthology)
Disease	Asymmetric crying face association	COMT RREB1	1.74e-03	10	187	2	C0431406
Disease	3-methyl-2-oxobutyrate measurement	GPI FAT4	1.74e-03	10	187	2	EFO_0021020
Disease	interventricular septum thickness	MAPT ITPR2	1.74e-03	10	187	2	EFO_0009287
Disease	22q11 Deletion Syndrome	COMT RREB1	1.74e-03	10	187	2	C2936346
Disease	C-reactive protein measurement	TRAF3IP2 IL12RB1 CAD MAP1A IFT172 CRTAC1 BCL3 RREB1 CBL PCDH17 MAP3K1 MADD PTK7 KCNE4 MACF1 FOXP1 TP53BP1	1.80e-03	1206	187	17	EFO_0004458
Disease	post-traumatic stress disorder symptom measurement	SYNE1 LRRC37A2 NBEA IFT52	1.86e-03	82	187	4	EFO_0008535
Disease	urate measurement, bone density	CASP8AP2 WDR64 WDR7 SYNE1 ETS2 PCDH17 ITPR2 TOX4 SALL2 KCNA5 MLC1	2.08e-03	619	187	11	EFO_0003923, EFO_0004531
Disease	ovarian carcinoma, COVID-19	MAPT KANSL1	2.12e-03	11	187	2	EFO_0001075, MONDO_0100096
Disease	Cystic Kidney Diseases	FAT4 ANKS6	2.12e-03	11	187	2	C1691228
Disease	Autism Spectrum Disorders	RYR2 NRXN2 FOXP1 PCDH9	2.12e-03	85	187	4	C1510586
Disease	interleukin 2 measurement	TRAF3IP2 ZBTB8B OPRK1	2.24e-03	41	187	3	EFO_0008331
Disease	platelet-to-lymphocyte ratio	COL11A2 RASA3 SPC25 RREB1 CBL LRCH1 BAZ2A FOXP1	2.31e-03	363	187	8	EFO_0008446
Disease	vital capacity	HSPG2 STRN3 MAPT UNC5B SYNE1 PIEZO1 RREB1 MAP3K1 RYR2 EFNA5 R3HCC1L KANSL1 DMRT2 FOXP1 PARP9 PARD3 VWA5B1	2.33e-03	1236	187	17	EFO_0004312
Disease	Breast Carcinoma	GPI COMT SYNE1 LRRC37A2 ETS2 MAP3K1 EEF2 LRRC37A HERC2 TP53BP1	2.39e-03	538	187	10	C0678222
Disease	Charcot-Marie-Tooth disease	WARS1 DRP2 FGD4	2.40e-03	42	187	3	cv:C0007959
Disease	neuroimaging measurement, brain volume measurement	STRN3 SPC25 GRB10 MAP3K1 KANSL1 LRCH4 NAV3	2.41e-03	286	187	7	EFO_0004346, EFO_0006930
Disease	Amelogenesis Imperfecta	TUFT1 PEX26	2.53e-03	12	187	2	C0002452
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	SYNE1 HOOK3	2.53e-03	12	187	2	DOID:11726 (implicated_via_orthology)
Disease	ADHD symptom measurement	NRL ARHGEF12	2.53e-03	12	187	2	EFO_0007860
Disease	atrial fibrillation	HSPG2 MAPT POLD1 CRTAC1 ITPR2 ZFHX4 SPEN CRAMP1	2.64e-03	371	187	8	EFO_0000275
Disease	body surface area	MCPH1 SPC25 ARHGEF12 GRB10 CRTAC1 RREB1 KCNE4 MACF1 PARD3 ARHGEF26 TASOR	2.79e-03	643	187	11	EFO_0022196
Disease	autism spectrum disorder (implicated_via_orthology)	NEXMIF ASH1L NBEA NRXN2 CHD6	2.89e-03	152	187	5	DOID:0060041 (implicated_via_orthology)
Disease	Short Rib-Polydactyly Syndrome	IFT172 IFT52	2.98e-03	13	187	2	C0036996
Disease	Nephronophthisis	ANKS6 NPHP4	2.98e-03	13	187	2	C0687120
Disease	reticulocyte measurement	RAB11B MAPT PIEZO1 ASH1L RREB1 CBL LRCH1 MAP3K1 KANSL1 DMRT2 MEGF9 USP42 MICAL2 MAST1 FOXP1	3.02e-03	1053	187	15	EFO_0010700
Disease	glucose measurement	WARS1 LRRC37A3 SPC25 GRB10 RREB1 MADD SLC5A3 LRRC37A	3.05e-03	380	187	8	EFO_0004468
Disease	platelet crit	ZCWPW1 MAP1A PIEZO1 ARHGEF12 RREB1 CBL APOBR ITPR2 KANSL1 TLN1 BANP NAV3 DCHS1 WDR24	3.12e-03	952	187	14	EFO_0007985
Disease	unipolar depression, bipolar disorder	DMTF1 FAT4 SYNE1 EFNA5 ASXL3	3.24e-03	156	187	5	EFO_0003761, MONDO_0004985
Disease	Salivary Gland Neoplasms	IGFBP2 MLC1 SPEN	3.31e-03	47	187	3	C0036095
Disease	actinic keratosis	FOXP1 HERC2	3.46e-03	14	187	2	EFO_0002496
Disease	Saldino-Noonan Syndrome	IFT172 IFT52	3.46e-03	14	187	2	C0036069
Disease	Majewski Syndrome	IFT172 IFT52	3.46e-03	14	187	2	C0024507
Disease	Arthritis, Psoriatic	TRAF3IP2 NOD2	3.46e-03	14	187	2	C0003872
Disease	polycystic kidney disease (implicated_via_orthology)	ANKS6 IFT172	3.46e-03	14	187	2	DOID:0080322 (implicated_via_orthology)
Disease	Bipolar Disorder	COMT SYNE1 DUSP6 DBN1 NEDD4 SLC5A3 NOD2 IGFBP2 MLC1	3.54e-03	477	187	9	C0005586
Disease	cholesteryl esters to total lipids in IDL percentage	BCL3 MACF1 TP53BP1	3.94e-03	50	187	3	EFO_0022247
Disease	Anilide use measurement	MAPT KANSL1	3.97e-03	15	187	2	EFO_0009938
Disease	Hypogonadotropic hypogonadism	SLC29A3 POLD1	3.97e-03	15	187	2	C0271623
Disease	Primary hypogonadism	SLC29A3 POLD1	3.97e-03	15	187	2	C0948896
Disease	Hypogonadism, Isolated Hypogonadotropic	SLC29A3 POLD1	3.97e-03	15	187	2	C3489396
Disease	DiGeorge Syndrome	COMT RREB1	4.52e-03	16	187	2	C0012236
Disease	CONOTRUNCAL ANOMALY FACE SYNDROME	COMT RREB1	4.52e-03	16	187	2	C0795907
Disease	Hypogonadism	SLC29A3 POLD1	4.52e-03	16	187	2	C0020619
Disease	Shprintzen syndrome	COMT RREB1	4.52e-03	16	187	2	C0220704
Disease	Parkinson disease	MAPT ASH1L NOD2 KANSL1 FGD4 ASXL3 PARP9	4.53e-03	321	187	7	MONDO_0005180
Disease	Uveal Melanoma	UNC5B RREB1 HERC2	4.65e-03	53	187	3	EFO_1000616
Disease	Muscle hypotonia	ABAT KANSL1	5.10e-03	17	187	2	C0026827
Disease	mean reticulocyte volume	CAD MAPT PCDHGA5 STK17A NEXMIF PIEZO1 GRB10 SAFB IFT52 KANSL1 MAST1 FOXP1	5.15e-03	799	187	12	EFO_0010701
Disease	intraocular pressure measurement	TRAF3IP2 MCPH1 PCDHGA5 ETS2 ARHGEF12 NEDD4 FOXP1 HERC2 BICC1	5.37e-03	509	187	9	EFO_0004695
Disease	cortical surface area measurement	STRN3 MCPH1 MAPT ARHGEF12 CRTAC1 RREB1 LRCH1 MAP3K1 GRIP1 EFNA5 KCNA5 KANSL1 DMRT2 NAV3 MACF1 FOXP1 PARD3	5.43e-03	1345	187	17	EFO_0010736
Disease	breast carcinoma	NRAP PHF20 MAPT ASH1L ARHGEF12 ANKLE1 RREB1 MAP3K1 MADD RPS6KC1 KANSL1 MAST1 FOXP1 FAM20A	5.64e-03	1019	187	14	EFO_0000305
Disease	Hypertrophic Cardiomyopathy	OBSCN FHOD3 RYR2	5.70e-03	57	187	3	C0007194
Disease	esophageal adenocarcinoma, digestive system disease, Barrett's esophagus	BCL3 FOXP1	5.72e-03	18	187	2	EFO_0000280, EFO_0000405, EFO_0000478

Protein segments in the cluster

Peptide	Gene	Start	Entry
APVSDHTAGAQTAEA	BANP	486	Q8N9N5
AVEQVAHGSQLDSEP	AMER3	781	Q8N944
RGDSEPLSEAAQAHT	RNF40	216	O75150
HIQDEPGTNDGSTEA	BDP1	1971	A6H8Y1
EEGAALHLSPDTVTD	ASH1L	1881	Q9NR48
ADPNLVLEDGAAAVH	ANKLE1	31	Q8NAG6
GHVEIPNLSDENSVD	AHSA1	101	O95433
SQEVGSGIHPDEAAE	BAZ2A	206	Q9UIF9
GTSVISVTAHDPDAD	FAT4	1436	Q6V0I7
SVTAHDPDADINGQL	FAT4	1441	Q6V0I7
SPGDENAESSIIHFE	BIRC3	351	Q13489
AESLEAALTHNAEVP	ACAP1	131	Q15027
HAGEESEVDNDVDSP	ARHGEF26	291	Q96DR7
ALAGHLNEVPDDSVQ	AGO4	136	Q9HCK5
SEDDLVAGATLHSPE	BICC1	31	Q9H694
SEAKSEGNHPALAVE	CASP8AP2	1746	Q9UKL3
SPHGFIQASDVIDTE	DMTF1	701	Q9Y222
SEHASGEPAATEHAE	ACRV1	91	P26436
EPVANEGIDHSSTFI	ASXL3	1526	Q9C0F0
EAHSDENPSEGDGAV	ARHGEF12	1386	Q9NZN5
DATPLHVARSGNDTE	R3HCC1L	421	Q7Z5L2
AHDESPGNNVVDISV	RAB11B	186	Q15907
NDDHLFEIDPSSGEI	PCDH17	631	O14917
IEPSSSHVAEGQTLD	HSPG2	2156	P98160
ADVEPVSASAAHILG	RASA3	311	Q14644
IFSVTAHDPDSGDNA	PCDHGA5	471	Q9Y5G8
PGAIDGHDSVVDNVS	PARP9	786	Q8IXQ6
GHDSVVDNVSSPETF	PARP9	791	Q8IXQ6
SVPHGNDIASLFELD	ITPR2	356	Q14571
DSPVAHLVAIDSNTG	PCDH12	501	Q9NPG4
SADGDPVQIDFIDSH	LRCH4	346	O75427
ASHIISEDGDNPEVG	PAXIP1	46	Q6ZW49
SDPDDGDFAHVNVSL	DCHS1	391	Q96JQ0
SSPDVHLTIQEEGAD	KCNE4	181	Q8WWG9
QEAAAEHPQTAEEGE	LRRC37A3	496	O60309
AEEGESSLTHQEAPA	LRRC37A3	506	O60309
LQGSDEDEHVRAPTG	MYF5	46	P13349
VAAPLAEEEHVSSAT	MAP1A	816	P78559
NVDPLTHAALGDASE	MADD	656	Q8WXG6
TAGAHIDESLFPAAN	MCPH1	81	Q8NEM0
LADSGSVPHDSQVAE	JSRP1	41	Q96MG2
QEAAAEHPQTAEEGE	LRRC37A2	496	A6NM11
AEEGESSLTHQEAPA	LRRC37A2	506	A6NM11
QEAAAEHPQTAEEGE	LRRC37A	496	A6NMS7
AEEGESSLTHQEAPA	LRRC37A	506	A6NMS7
TSTDPFVQDDLEHGL	NEDD4	231	P46934
ISPSEIAHNEDGTSA	NEDD4	301	P46934
ALEHSPSGFDINTAV	INKA2	281	Q9NTI7
AVEAGDHQSGEVNPD	NRAP	1701	Q86VF7
DHQSGEVNPDATEIL	NRAP	1706	Q86VF7
NDSSELIGPAEAHSD	RPS6KC1	131	Q96S38
PAVQETGTVHTDDGA	HERC2	2346	O95714
HQNSLPELEAAEAGA	LENG1	56	Q96BZ8
PAHGRSASSLEDADD	KIAA2026	41	Q5HYC2
IVEPIQSEGGDNHAS	ABAT	291	P80404
SEAEAPDKHGSASFV	CDKN2AIP	231	Q9NXV6
HADTVGIDAVLQPSA	C1orf109	116	Q9NX04
APIHDADAQESSLGL	DKKL1	31	Q9UK85
GTSVIQVTAHDADDP	CDH24	166	Q86UP0
FDVEPSLHSGINAAV	MAP3K6	386	O95382
QESDASAPHAAEAGS	IGFBP1	106	P08833
ASPEQVADNGDDHSE	IGFBP2	141	P18065
PVGTSVIQLHATDAD	PCDH9	266	Q9HC56
ANHAVAEEPAGTSLE	PEX26	66	Q7Z412
RAHSENEGTALPSAD	NAV3	636	Q8IVL0
EVPTGLDSISHDSAN	ETS2	51	P15036
HIVNGERDETATAPA	FGD4	126	Q96M96
GSPEETGAQHVQLAE	NRL	116	P54845
TPAVDIGAADLAHAQ	FOXP1	41	Q9H334
EETELGPALSAETAH	COL11A2	356	P13942
LADHIPGDSSDAEEQ	KANSL1	556	Q7Z3B3
ASDHSGSPEQQLDEK	JAKMIP3	276	Q5VZ66
APGHDLSDTVQADLS	LRCH1	91	Q9Y2L9
HDSIPNADVSGLLED	MEGF9	566	Q9H1U4
EPELDGSAQVTSHDA	GPI	526	P06744
VEPATADATEIHDAA	DBN1	436	Q16643
GAAESPDLAASAELH	NKX2-8	146	O15522
PPDEHQEAENAVSSG	NUSAP1	136	Q9BXS6
VDLGITADSSNHPDN	PTPRZ1	1736	P23471
PDVNLIGEHSDAAEL	HOOK3	101	Q86VS8
ATEPHEGRADEQSAE	GPR83	16	Q9NYM4
EQSAEAALAVPNASH	GPR83	26	Q9NYM4
QNGLDHPSVEVSLDE	IKZF5	51	Q9H5V7
LSHDSIFIPESGQDA	CRACDL	91	Q6NV74
PDVVHLEEQDSGGSN	MAST1	336	Q9Y2H9
PDGSDASQLLHQAEV	MACF1	5086	Q9UPN3
QFSLGSEEHLDAPTE	NPHP4	446	O75161
AAQRVAEAHDPDSVA	IFT172	1186	Q9UG01
HTGSKEVLDDNANPA	PPP1R3A	431	Q16821
PAHREVQAEAGASAT	OBSCN	1631	Q5VST9
EPEEALNGHSSIDVS	NID2	331	Q14112
ALAAESDPNVRTEGH	NRXN2	276	P58401
QSAVPLDGETHAGED	ALPG	441	P10696
ENVALATGTLDSPAH	OSGIN2	256	Q9Y236
HAEPGNAQSVLEAID	COMT	66	P21964
TTGDIHLNQIDAEDP	IFT52	241	Q9Y366
EADNQGTHFSSIPDA	KCNA5	456	P22460
FSPIVDTDSLAAQGH	DMRT2	436	Q9Y5R5
SEPEAAEHSFSNGAA	CHD6	2141	Q8TD26
EVVVEGPAASTELHN	COL20A1	421	Q9P218
HAPGSSQEADLDAEL	DAGLB	261	Q8NCG7
DALSQGEPATHISDS	CRAMP1	1086	Q96RY5
DEPNGASSDHITEAF	FAM120C	531	Q9NX05
VADEAGQDIASAHEG	FHOD3	576	Q2V2M9
LAAEGSHVTANVVDP	DHRSX	226	Q8N5I4
DLEGPVAAGDSSHQE	AKNAD1	196	Q5T1N1
IADEDPSHVNLVNGD	ANKS6	311	Q68DC2
GHVEAAPETTAVSAE	MGARP	141	Q8TDB4
ADTHTEPVALNISVG	IL12RB1	336	P42701
TVHESAEPSRGENAA	EFNA5	191	P52803
ENPAEAQSAALEEGH	GRB10	446	Q13322
AAAHANTGPEESENE	CBL	756	P22681
FVDAAASAGVDDPHQ	CRTAC1	276	Q9NQ79
NLIDSPGHVDFSSEV	EEF2	101	P13639
HGAISEDQAVGPADI	DCTPP1	146	Q9H773
HLSDLGDVEEDSSPA	GRIP1	771	Q9Y3R0
ADEDGDTPLHIAVVQ	BCL3	131	P20749
AGSPEVLHAQELEAS	DHX34	846	Q14147
ESSHIESAINVAIPG	DUSP6	46	Q16828
GAESSQEPVAHTVSE	SASH3	326	O75995
SSVNPVLEETHEGEA	SLC19A3	211	Q9BZV2
AHIEDPEDTNQGISG	S100PBP	331	Q96BU1
ASENGDASEEDHPQV	SALL2	21	Q9Y467
APDQDHAARAEVCSG	RYR2	1066	Q92736
DPEGAVAHAQDVISD	POLD1	856	P28340
QHVVEAPDGAAAAAS	PRRT3	886	Q5FWE3
APSLADGSTEAATDH	DRP2	816	Q13474
HSASSDQDPVADREG	GARNL3	976	Q5VVW2
KSISEPQHSDAEGDA	MICAL2	1121	O94851
ADTGLEHIPNFSLDD	PARD3	256	Q8TEW0
DDFGSSNAPAVDLDH	PHF20	436	Q9BVI0
DAVNPLHENGDDSLS	PHF20	866	Q9BVI0
SAGSEDAQLEPAHIS	OPRK1	41	P41145
NHLAAESPGEVQASA	MAP3K1	226	Q13233
PTDQAAAGTDAEHVQ	NR4A3	421	Q92570
VNPSGAREEQEAHTD	RTL1	126	A6NKG5
SNHGPDATEAEEDFV	WARS1	71	P23381
AAHVFSGEEELPQDS	SLC29A3	266	Q9BZD2
AHLDAVTSLAVDPNG	STRN3	721	Q13033
SDDPQVLAVAAHDVG	ATP6V1H	401	Q9UI12
FEDAVDHLATASQGP	TBC1D25	481	Q3MII6
AEEILQGQDPSHSSD	SYNE1	7371	Q8NF91
DHPNASRDSVEGDAL	MIA3	586	Q5JRA6
LSAAFVDENLPDGTH	NBR1	371	Q14596
STEEDAGALAPAHIS	PKNOX1	411	P55347
LGLIEAPEHAANSAS	NEXMIF	81	Q5QGS0
DSAAAASDPGTIVHN	FAM20A	56	Q96MK3
GEDIQVESSIPHTDS	NBEA	1661	Q8NFP9
EEGNPVASLGHSEAE	SLC5A3	611	P53794
VASLGHSEAETPVDA	SLC5A3	616	P53794
AHPLGEFEDQQLASD	RNF216	236	Q9NWF9
EDEEVSAELGHQAPS	HRC	426	P23327
GQNEADSAPEDLHSV	FAM13C	206	Q8NE31
SHGGVNIEDVAAESP	SUCLA2	186	Q9P2R7
PHTAALDQAVGAAVT	RRP12	526	Q5JTH9
PEEGDLDLASESTAH	SAFB	266	Q15424
ALEEANALQEGHSVP	STK17A	336	Q9UEE5
DSAPHLEGLAEFQEN	SPC25	186	Q9HBM1
HEQPQDSSEAGAAAL	TASOR	71	Q9UK61
ALNEHPSVAESAVVS	ACSM3	496	Q53FZ2
THQAPAEAAPESVGE	APOBR	951	Q0VD83
ASESVVGALPAEHQF	TRAF3IP2	126	O43734
VDVHPEDQAAGSVDI	TUFT1	11	Q9NNX1
IVSSHSPGQDAEDEE	USP42	631	Q9H9J4
AAHPSEIARGDEDSS	ZFHX4	571	Q86UP3
EIARGDEDSSATPHQ	ZFHX4	576	Q86UP3
IECEDPVDHVGNATA	TM2D2	81	Q9BX73
VGDAASAETASVTHP	USPL1	536	Q5W0Q7
SATDTDNANGEEVPH	ZCWPW1	151	Q9H0M4
AATHGPADCSEEVAE	ZNF668	41	Q96K58
SAADQGAHIIVTPED	VNN1	66	O95497
HSEDGEASIVVNNPD	PIGX	156	Q8TBF5
PAHQASETELAAAIG	SPEN	2206	Q96T58
LFSTPGHLNDDADTV	NOD2	281	Q9HC29
EDNTQDEVAGAPADH	RREB1	1201	Q92766
VEAAKGAAAHPDSEE	TLN1	871	Q9Y490
KPAAVAAENEEIGSH	TLN1	1901	Q9Y490
AELAAHEPAIQGVLD	SPTAN1	1811	Q13813
AEEEPEAGDSVGNVH	ZBTB41	331	Q5SVQ8
AASLEEVAPGARHAT	FLT4	621	P35916
SESPQHDVVDLGSTA	TMEM102	216	Q8N9M5
LLTESHSEDEVAGPA	VWA2	451	Q5GFL6
TPSLEDEAAGHVTQE	MAPT	111	P10636
QPESQVLEDDSGSHF	TP53BP1	26	Q12888
AAAAASHDKGPEAEE	USF2	16	Q15853
SDPNSHLLEASGDAA	UNC5B	361	Q8IZJ1
GEHVAPSEAANSLEQ	CAD	526	P27708
AFPGENALEHSSDQD	ZNF839	606	A8K0R7
AEHSAKPSDAEASEG	ZNF512B	561	Q96KM6
EDSRDEGLGVATPHQ	PIEZO1	756	Q92508
AHVASLEGIAPEDQV	FAU	26	P62861
GHPEAQESTAGDENR	TCHHL1	651	Q5QJ38
HVSGSEADVASLAPV	WDR24	596	Q96S15
VLQEENPLAGTEDHS	VEGFD	236	O43915
NGSLVIHDVAPEDSG	PTK7	646	Q13308
AAPVVSARSDADHSG	WDR7	951	Q9Y4E6
LTEGEVQAAAPSHSS	TBRG1	86	Q3YBR2
VGHFDDLADPSSSQD	TOX4	56	O94842
AGVESPTHEIRADAA	VWA5B1	236	Q5TIE3
PHGFNTEVTSAAVDE	WDR64	496	B1ANS9
AHVEEALPSGQAVDL	ZBTB8B	256	Q8NAP8
ASDEATGQGHVVESP	GARIN5B	301	Q8N5Q1
PGQDEQVASEEFLSH	KIAA1958	331	Q8N8K9
ALNVDDSVSGPHLSV	MLC1	216	Q15049
PHCDSQTAVIEDAGS	NACC2	126	Q96BF6